Pyrrolidone-doped cellulose acetate nanofibers: a preliminary field evaluation in a mobile air filtration unit for clinical use
Pharmacy Reports · 2026
DOI: 10.51511/pr.132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacy Reports, 2026. Verfasst von Amin Saiff Johari und 3 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Airborne microbial contamination remains a persistent threat to patient safety in clinical settings, and conventional bioaerosol control strategies, particularly HEPA-based filtration, are limited by their inability to inactivate trapped microorganisms, which can continue to proliferate within the filter and recirculate into the air. This study presents a preliminary field evaluation of pyrrolidone-doped cellulose acetate (CA) nanofibers integrated into a mobile air filtration unit, aimed at reducing airborne microbial burden in a real clinical environment. The filtration unit was deployed for four weeks in an observation ward at a general hospital, and antibacterial efficacy was assessed using in situ filter sampling and active air sampling, with isolate identification performed via 16S rRNA gene sequencing. The pyrrolidone-doped CA filter achieved a significant reduction in bacterial colony counts of 51.70% at week 1 (p < 0.05), though the reduction observed at week 4 (21.68%) was not statistically significant. Active air sampling showed corresponding, non-significant reductions in airborne bacterial load of 9.52% at week 1 and 5% at week 4. Four bacterial genera were isolated from the ward air, namely Bacillus, Staphylococcus, Priestia, and Acinetobacter, including Acinetobacter baumannii, a WHO priority pathogen associated with multidrug resistance. These findings provide preliminary evidence that pyrrolidone-doped CA nanofiber filtration can meaningfully reduce short-term airborne bacterial burden in a clinical setting, while also highlighting a decline in efficacy over prolonged use that warrants further investigation into filter longevity and replacement intervals. Larger-scale, controlled studies are needed to validate this strategy as a viable adjunct for improving indoor air quality and reducing hospital-acquired infection risk.
Zitieren
APA
Johari, A. S., Salleh, S. N. M., Seeni, A., & Othman, M. H. (2026). Pyrrolidone-doped cellulose acetate nanofibers: a preliminary field evaluation in a mobile air filtration unit for clinical use. Pharmacy Reports. https://doi.org/10.51511/pr.132
Vancouver
Johari AS, Salleh SNM, Seeni A, Othman MH. Pyrrolidone-doped cellulose acetate nanofibers: a preliminary field evaluation in a mobile air filtration unit for clinical use. Pharmacy Reports. 2026. doi:10.51511/pr.132
BibTeX
@article{Johari2026,
author = {Johari, Amin Saiff and Salleh, Shahrul Nizam Md and Seeni, Azman and Othman, Muhamad Hazri},
title = {Pyrrolidone-doped cellulose acetate nanofibers: a preliminary field evaluation in a mobile air filtration unit for clinical use},
journal = {Pharmacy Reports},
year = {2026},
doi = {10.51511/pr.132}
}
EUVIMED